

Psychedelic Health Insurance Benefits with Sherry Rais
4 snips Feb 14, 2024
Sherry Rais, CEO of Anthea, discusses pioneering accessible psychedelic-assisted therapies, starting with ketamine treatment. They explore the transformative potential of these therapies, challenges in integrating psychedelic therapy into insurance policies, and the benefits of offering ketamine therapy as an employee benefit. The podcast also addresses stigma associated with psychedelic therapy, underutilization of mental health benefits post-COVID, and the importance of personalized treatments for better mental health outcomes.
Chapters
Transcript
Episode notes
1 2 3 4 5 6
Introduction
00:00 • 4min
Exploring the Benefits and Challenges of Ketamine Therapy in Employer Benefits
04:09 • 18min
Challenges in Psychedelic Therapy and Mental Health Benefits
22:27 • 3min
Challenges and Solutions in Increasing Mental Health Service Utilization
25:23 • 2min
Exploring a Unique Health Insurance Model and Measuring Employee Productivity
27:20 • 3min
Exploring the Benefits of Psychedelic Therapy in Health Insurance
29:57 • 3min